US 2005/0089478 A1Published application

Composition for inhalation

AssigneeAstraZeneca AB

InventorsNayna Govind, Maria Marlow

Life of this patent

Estimating the term…

Abstract

The invention relates to a formulation comprising formoterol and budesonide for use in the treatment of respiratory diseases. The composition further contains HFA 227, PVP and PEG, preferably PVP K25 and PEG 1000.

Claims12

Dependent claims

A pharmaceutical composition comprising formoterol, budesonide, HFA 227, PVP and PEG.

Dependencies are inferred from the claim text.

Facts

Application: 10/502,685Filed 29 Jan 2003
Priority: SE 0200312-71 Feb 2002
Published: 28 Apr 2005
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 31/58
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids: containing heterocyclic rings, e.g. danazol,…
A61K 9/008
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy: comprising drug dissolved or…
A61K 31/167
Having aromatic rings, e.g. colchicine, atenolol, progabide: having the nitrogen of a carboxamide group directly attached to the aromatic ring,…
A61K 31/194
Carboxylic acids, e.g. valproic acid: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid

Family

US 7,759,328 B2Related patent
US 2005/0089478 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results